| Título : |
Endocrine Disrupting Chemicals-induced Metabolic Disorders and Treatment Strategies |
| Tipo de documento: |
documento electrónico |
| Autores: |
Akash, Muhammad Sajid Hamid, ; Rehman, Kanwal, ; Hashmi, Muhammad Zaffar, |
| Mención de edición: |
1 ed. |
| Editorial: |
[s.l.] : Springer |
| Fecha de publicación: |
2021 |
| Número de páginas: |
XXV, 520 p. 176 ilustraciones, 98 ilustraciones en color. |
| ISBN/ISSN/DL: |
978-3-030-45923-9 |
| Nota general: |
Libro disponible en la plataforma SpringerLink. Descarga y lectura en formatos PDF, HTML y ePub. Descarga completa o por capítulos. |
| Palabras clave: |
química ambiental Enfermedades Farmacología |
| Índice Dewey: |
577.14 |
| Resumen: |
Este volumen ofrece un análisis detallado y completo de las sustancias químicas disruptoras endocrinas (EDC), que abarca su aparición, la exposición de los seres humanos y los mecanismos que conducen a la partegénesis de los trastornos metabólicos inducidos por las EDC. El libro está dividido en tres partes. La Parte I describe la fisiología del sistema endocrino humano, con especial énfasis en varios tipos de trastornos metabólicos junto con los factores de riesgo que son responsables del desarrollo de estos trastornos. La Parte II aborda todos los aspectos de los EDC, incluido su papel en la inducción de diversos factores de riesgo que son responsables del desarrollo de trastornos metabólicos. La Parte III cubre consideraciones regulatorias ambientales actualizadas y estrategias de tratamiento que se han adoptado para curar y prevenir los trastornos metabólicos inducidos por los EDC. Esta sección será de interés principalmente para los médicos que investigan las causas y el tratamiento de los trastornos metabólicos. El texto también será de interés para estudiantes e investigadores en los campos de Farmacología y Toxicología Ambiental, Contaminación Ambiental, Bioquímica Farmacéutica, Biotecnología y Metabolismo/Farmacocinética de Fármacos. |
| Nota de contenido: |
Part I: Introduction to endocrine system and metabolic disorders. - Chapter 1: Physiology of endocrine system and related metabolic disorders -- Chapter 2: Impaired carbohydrate metabolism in metabolic disorders -- Chapter 3: Mitochondrial dysfunction in metabolic disorders -- Chapter 4: Inherited metabolic disorders-a current status -- Chapter 5: Impaired lipid metabolism in metabolic disorders -- Chapter 6: Impaired thyroid function in metabolic disorders. - Part II: Role of endocrine disrupting chemicals in metabolic disorders -- Chapter 7: Endocrine-disrupting chemicals: Occurrence and exposure to the human being -- Chapter 8: Antibiotic resistance in EDCs-induced metabolic disorders -- Chapter 9: Alteration of gut microbiota in EDCs-induced metabolic disorders -- Chapter 10: Endocrine disrupting chemicals induced childhood obesity -- Chapter 11: Role of polychlorinated biphenyls as EDCs in metabolic disorders -- Chapter 12: Role of furans as EDCs in metabolic disorders -- Chapter 13: Role of heavy metals in metabolic disorders -- Chapter 14: Role of flame-retardants as EDCs in metabolic disorders -- Chapter 15: Role of phthalates as EDCs in metabolic disorders. - Chapter 16: Bisphenol A as an EDC in metabolic disorders -- Chapter 17: Role of pesticides as EDCs in metabolic disorders -- Chapter 18: Role of perfluoroalkyl substances as EDCs in metabolic disorders -- Chapter 19: Role of polycyclic aromatic hydrocarbons as EDCs in metabolic disorders -- Chapter 20: Tobacco smoking as an EDC in metabolic disorders -- Chapter 21: Role of pharmaceuticals as EDCs in metabolic disorders -- Chapter 22: Parabens as endocrine disrupting chemicals and their association with metabolic disorders -- Chapter 23: Role of aflatoxins as EDCs in metabolic disorders -- Part III: Treatment strategies of EDCs-induced metabolic disorders: From prevention to intervention -- Chapter 24: Hormone harmony in metabolic disorders -- Chapter 25: Role of nanoparticles in the management ofmetabolic disorders -- Chapter 26: Intermittent fasting for treatment of metabolic disorders -- Chapter 27: rbs and spices as natural medicine for treatment of metabolic disorders -- Chapter 28: Bioactive compounds for the treatment of metabolic disorders. |
| En línea: |
https://link-springer-com.biblioproxy.umanizales.edu.co/referencework/10.1007/97 [...] |
| Link: |
https://biblioteca.umanizales.edu.co/ils/opac_css/index.php?lvl=notice_display&i |
Endocrine Disrupting Chemicals-induced Metabolic Disorders and Treatment Strategies [documento electrónico] / Akash, Muhammad Sajid Hamid, ; Rehman, Kanwal, ; Hashmi, Muhammad Zaffar, . - 1 ed. . - [s.l.] : Springer, 2021 . - XXV, 520 p. 176 ilustraciones, 98 ilustraciones en color. ISBN : 978-3-030-45923-9 Libro disponible en la plataforma SpringerLink. Descarga y lectura en formatos PDF, HTML y ePub. Descarga completa o por capítulos.
| Palabras clave: |
química ambiental Enfermedades Farmacología |
| Índice Dewey: |
577.14 |
| Resumen: |
Este volumen ofrece un análisis detallado y completo de las sustancias químicas disruptoras endocrinas (EDC), que abarca su aparición, la exposición de los seres humanos y los mecanismos que conducen a la partegénesis de los trastornos metabólicos inducidos por las EDC. El libro está dividido en tres partes. La Parte I describe la fisiología del sistema endocrino humano, con especial énfasis en varios tipos de trastornos metabólicos junto con los factores de riesgo que son responsables del desarrollo de estos trastornos. La Parte II aborda todos los aspectos de los EDC, incluido su papel en la inducción de diversos factores de riesgo que son responsables del desarrollo de trastornos metabólicos. La Parte III cubre consideraciones regulatorias ambientales actualizadas y estrategias de tratamiento que se han adoptado para curar y prevenir los trastornos metabólicos inducidos por los EDC. Esta sección será de interés principalmente para los médicos que investigan las causas y el tratamiento de los trastornos metabólicos. El texto también será de interés para estudiantes e investigadores en los campos de Farmacología y Toxicología Ambiental, Contaminación Ambiental, Bioquímica Farmacéutica, Biotecnología y Metabolismo/Farmacocinética de Fármacos. |
| Nota de contenido: |
Part I: Introduction to endocrine system and metabolic disorders. - Chapter 1: Physiology of endocrine system and related metabolic disorders -- Chapter 2: Impaired carbohydrate metabolism in metabolic disorders -- Chapter 3: Mitochondrial dysfunction in metabolic disorders -- Chapter 4: Inherited metabolic disorders-a current status -- Chapter 5: Impaired lipid metabolism in metabolic disorders -- Chapter 6: Impaired thyroid function in metabolic disorders. - Part II: Role of endocrine disrupting chemicals in metabolic disorders -- Chapter 7: Endocrine-disrupting chemicals: Occurrence and exposure to the human being -- Chapter 8: Antibiotic resistance in EDCs-induced metabolic disorders -- Chapter 9: Alteration of gut microbiota in EDCs-induced metabolic disorders -- Chapter 10: Endocrine disrupting chemicals induced childhood obesity -- Chapter 11: Role of polychlorinated biphenyls as EDCs in metabolic disorders -- Chapter 12: Role of furans as EDCs in metabolic disorders -- Chapter 13: Role of heavy metals in metabolic disorders -- Chapter 14: Role of flame-retardants as EDCs in metabolic disorders -- Chapter 15: Role of phthalates as EDCs in metabolic disorders. - Chapter 16: Bisphenol A as an EDC in metabolic disorders -- Chapter 17: Role of pesticides as EDCs in metabolic disorders -- Chapter 18: Role of perfluoroalkyl substances as EDCs in metabolic disorders -- Chapter 19: Role of polycyclic aromatic hydrocarbons as EDCs in metabolic disorders -- Chapter 20: Tobacco smoking as an EDC in metabolic disorders -- Chapter 21: Role of pharmaceuticals as EDCs in metabolic disorders -- Chapter 22: Parabens as endocrine disrupting chemicals and their association with metabolic disorders -- Chapter 23: Role of aflatoxins as EDCs in metabolic disorders -- Part III: Treatment strategies of EDCs-induced metabolic disorders: From prevention to intervention -- Chapter 24: Hormone harmony in metabolic disorders -- Chapter 25: Role of nanoparticles in the management ofmetabolic disorders -- Chapter 26: Intermittent fasting for treatment of metabolic disorders -- Chapter 27: rbs and spices as natural medicine for treatment of metabolic disorders -- Chapter 28: Bioactive compounds for the treatment of metabolic disorders. |
| En línea: |
https://link-springer-com.biblioproxy.umanizales.edu.co/referencework/10.1007/97 [...] |
| Link: |
https://biblioteca.umanizales.edu.co/ils/opac_css/index.php?lvl=notice_display&i |
|  |